Carter Neild
Private Equity Investor at OrbiMed Advisors LLC
Network origin in Carter Neild first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The University of Chicago
372
| College/University | Other Consumer Services | 372 |
Emory University
147
| College/University | Other Consumer Services | 147 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
100
| Subsidiary | Investment Managers | 100 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.
53
| Private Company | Investment Managers | 53 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carter Neild via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Public Communications Contact Private Equity Analyst | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| Drexel University | College/University | Graduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| Trinity College (Connecticut) | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| SCULPTOR CAPITAL MANAGEMENT, INC. | Investment Managers | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
| INSULET CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Centerbridge Partners LP
 Centerbridge Partners LP Investment ManagersFinance Centerbridge Partners LP(Centerbridge Partners) is a private equity firm founded in 2005 by Jeffrey Harold Aronson and Timothy Gallogly. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| FORTRESS INVESTMENT GROUP LLC | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Perfuse Therapeutics, Inc. operates as biotechnology company that focuses on retinal perfusion. The company was founded by Sevgi Gurkan in 2018 and is headquartered in San Francisco,CA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| ENTERO HEALTHCARE SOLUTIONS LIMITED | Medical Distributors | Director/Board Member Director/Board Member | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 42 |
| Ireland | 3 |
| Canada | 3 |
| United Kingdom | 3 |
| Israel | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 18 |
| Finance | 9 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 415 |
| Corporate Officer/Principal | 134 |
| Independent Dir/Board Member | 110 |
| Private Equity Investor | 97 |
| Undergraduate Degree | 94 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Peter Thompson | 39 |
| Chau Khuong | 38 |
| Erez Chimovits | 30 |
| Joseph Zakrzewski | 30 |
| Iain Dukes | 30 |
| Rishi Gupta | 29 |
| Sunny Sharma | 29 |
| Guo-Liang Yu | 27 |
| David Bonita | 27 |
| Dina Chaya | 23 |
| Jagdish Nanchand Sheth | 22 |
| Sheila Gujrathi | 20 |
| Raymond Schinazi | 19 |
- Stock Market
- Insiders
- Carter Neild
- Company connections
